Literature DB >> 2724426

Cardiovascular evaluation before circulatory arrest for removal of vena caval extension of renal carcinoma.

J A Belis1, W E Pae, T J Rohner, J L Myers, B L Thiele, G S Wickey, D E Martin.   

Abstract

The use of cardiopulmonary bypass, deep hypothermia and circulatory arrest has decreased the risks of hemorrhage, tumor embolization, incomplete thrombus resection, and warm hepatic and renal ischemia associated with resection of renal cell carcinoma extending into the inferior vena cava above the hepatic veins. Patients about to undergo this operation frequently have significant coronary artery and carotid artery disease, and are at risk for perioperative myocardial infarction and stroke. Preoperative evaluation of the coronary artery and carotid artery circulation by coronary angiography, duplex carotid artery scan and digital subtraction carotid angiography is recommended. Depending upon the severity and location of the cardiovascular disease a sequential or simultaneous operation may be performed. This surgical approach can be used in selected patients to facilitate complete tumor thrombectomy with a low operative risk.

Entities:  

Mesh:

Year:  1989        PMID: 2724426     DOI: 10.1016/s0022-5347(17)41288-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi.

Authors:  A C Novick; M C Kaye; D M Cosgrove; K Angermeier; J E Pontes; J E Montie; S B Streem; E Klein; R Stewart; M Goormastic
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

2.  Transabdominal two-cavity approach for radical nephrectomy combined with inferior vena cava thrombectomy for malignant thrombus caused by renal cell carcinoma: a case series.

Authors:  R Novotny; J Chlupac; T Marada; V Borovicka; V Vik; L Voska; L Janousek; Jiri Fronek
Journal:  J Med Case Rep       Date:  2018-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.